Concepedia

Hans-Peter Gschwind

HG

10

Publications

537

Citations

10

H-Index

1979

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Hans-Peter Gschwind is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1979–2014

10

Publications

10

METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS

Hans-Peter Gschwind, Ulrike Pfaar, Felix Waldmeier et al. · Drug Metabolism and Disposition · 2005 · 219 citations

Metabolism and Disposition of Vatalanib (PTK787/ZK-222584) in Cancer Patients

Lorenz Jost, Hans-Peter Gschwind, T. Jalava et al. · Drug Metabolism and Disposition · 2006 · 75 citations

Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents

Terence O’Reilly, Paul M.J. McSheehy, R. Kawai et al. · Cancer Chemotherapy and Pharmacology · 2009 · 65 citations

, , +6

Absorption and Disposition of the Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) in Healthy Volunteers: A Case of Xenobiotic Biotransformation Following Endogenous Metabolic Pathways

Markus Zollinger, Hans-Peter Gschwind, Yi Jin et al. · Drug Metabolism and Disposition · 2010 · 48 citations

An iron stable isotope comparison between human erythrocytes and plasma

Friedhelm von Blanckenburg, Marcus Oelze, Dietmar G. Schmid et al. · Metallomics · 2014 · 28 citations · Full text

Rows per page

1–5 of 10